Raymond James Maintains Outperform on Cambium Networks, Lowers Price Target to $25
Raymond James analyst Simon Leopold maintains Cambium Networks (NASDAQ:CMBM) with a Outperform and lowers the price target from $26 to $25.
Earnings Scheduled For February 16, 2023
Companies Reporting Before The Bell
• RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022.
• Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year 2022.
Intellia Therapeutics To Rally Around 143%? Plus Stifel Cuts PT On This Stock By 94%
Chardan Capital boosted the price target on Intellia Therapeutics, Inc. (NASDAQ: NTLA) from $121 to $129. Intellia Therapeutics shares fell 3% to close at $53.30 on Monday.
Block, MasTec, Universal Display And Some Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Friday. Here are some big stocks recording gains in today’s session.
Cambium Networks Sees Q4 Revenue $80M-$84M Vs $82.86M Est., Adj. EPS $0.23-$0.27 Vs $0.28 Est.
Fourth Quarter 2022 Financial Outlook
Taking into account our current visibility, the financial outlook as of November 3, 2022, for the fourth
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell
• Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.
Looking Into Cambium Networks’s Return On Invested Capital
According to Benzinga Pro, during Q2, Cambium Networks (NASDAQ:CMBM) earned $2.32 million, a 248.09% increase from the preceding quarter. Cambium Networks also posted a total of $69.30 million in sales, a 11.96% increase since Q1.